CONDENSED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income (loss)	$ 8,325,417	$ (2,871,225)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Formation cost paid by the Sponsor in exchange for issuance of the Founder Shares	0	5,000
Interest income on investments held in the Trust Account	(637,094)	(5,316)
Transaction costs allocated to the Warrants	0	208,936
Change in fair value of warrant liability	(8,597,274)	1,898,329
Changes in operating assets and liabilities
Prepaid expenses	408,915	(795,102)
Accrued expenses	45,270	194,238
Net cash used in operating activities	(454,766)	(1,365,140)
Cash flows from investing activities
Investment of cash in the Trust Account	0	(155,250,000)
Net cash used in investing activities	0	(155,250,000)
Cash flows from financing activities
Proceeds from sale of the Units, net of underwriting discounts paid	0	152,145,000
Proceeds from sale of the Private Placement Warrants	0	6,105,000
Repayment of the Promissory Note—related party	0	(43,101)
Payment of offering costs	0	(381,575)
Net cash provided by financing activities	0	157,825,324
Net change in cash	(454,766)	1,210,184
Cash—beginning of period	1,147,287	0
Cash—end of period	692,521	1,210,184
Non-cash investing and financing activities
Offering costs paid by the Sponsor in exchange for issuance of the Founder Shares	0	20,000
Offering costs paid through the Promissory Note	0	43,101
Deferred underwriting fee payable	$ 0	$ 5,433,750